COVID-19 Disease. COVID-19
Conditions
Interventions
Intervention 1: Control group: Standared treatment for COVID-19 according to hospital protocol for admitted patients. Intervention 2: Intervention group: The case group will be given three products in
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: age between 18 to 90 year old without any psychological problem drug consumption compliance hospital admission during recent 48 hours
Exclusion criteria
Exclusion criteria: Allergy to honey products warfarin usage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dyspnea grade. Timepoint: Dyspnea grade before intervention and daily after starting the intervention. Method of measurement: dyspnea grading according to New York heart association classification.;White blood cells (WBC) count. Timepoint: lab test before intervention and 3, and 7 days after intervention. Method of measurement: lab data assessment by blood sample.;Neutrophil to Lymphocyte count. Timepoint: lab test before intervention and 3, and 7 days after intervention. Method of measurement: lab data assessment by blood sample.;Interleukin-6 (IL-6) Level. Timepoint: lab test before intervention and 3, and 7 days after intervention. Method of measurement: lab data assessment by blood sample.;Anti SARS-Cov-2 IgG Level. Timepoint: one month after intervention. Method of measurement: blood sample.;C-reactive protein (CRP) level. Timepoint: lab test before intervention and 3, and 7 days after intervention. Method of measurement: lab data assessment by blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospital stay. Timepoint: duration of hospitalisation. Method of measurement: Hospital records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShadi Shafaghi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed